Molecular Bases of Drug Resistance in Hepatocellular Carcinoma

The poor outcome of patients with non-surgically removable advanced hepatocellular carcinoma (HCC), the most frequent type of primary liver cancer, is mainly due to the high refractoriness of this aggressive tumor to classical chemotherapy. Novel pharmacological approaches based on the use of inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Marin, Jose J.G., Macias, Rocio I.R., Monte, Maria J., Romero, Marta R., Asensio, Maitane, Sanchez-Martin, Anabel, Cives-Losada, Candela, Temprano, Alvaro G., Espinosa-Escudero, Ricardo, Reviejo, Maria, Bohorquez, Laura H., Briz, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352164/
https://www.ncbi.nlm.nih.gov/pubmed/32585893
http://dx.doi.org/10.3390/cancers12061663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352164/
https://www.ncbi.nlm.nih.gov/pubmed/32585893
http://dx.doi.org/10.3390/cancers12061663

Ejemplares similares